FDA inspection
Guilin China Resources Tianhe Pharmaceutical Co., Ltd.: FDA inspection ending Jan 11, 2019
FDA inspection 1078047 · Voluntary Action Indicated (VAI) · Guilin
Key facts
| Inspection ID | 1078047 |
|---|---|
| Firm | Guilin China Resources Tianhe Pharmaceutical Co., Ltd. |
| FEI number | 3003704959 |
| Address | 43 Quilidan Road, Xicheng Devel. Z, Lushan Road; Linguixian |
| City | Guilin |
| Country | China |
| Fiscal year | 2019 |
| Inspection end date | Jan 11, 2019 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data